Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date

por Chau, Vincent, Bilusic, Marijo
Publicado 2020

Anti-angiogenesis in prostate cancer: knocked down but not out

por Bilusic, Marijo, Wong, Yu-Ning
Publicado 2014

Nivolumab-associated acute glomerulonephritis: a case report and literature review

por Jung, Kyungsuk, Zeng, Xu, Bilusic, Marijo
Publicado 2016

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

por Peinetti, Nahuel, Bilusic, Marijo, Burnstein, Kerry L.
Publicado 2022

Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response

por Kim, Joseph W., Bilusic, Marijo, Heery, Christopher J., Madan, Ravi A.
Publicado 2012

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

por Monge, Cecilia, Maeng, Hoyoung, Brofferio, Alessandra, Apolo, Andrea B., Sathya, Bharath, Arai, Andrew E., Gulley, James L., Bilusic, Marijo
Publicado 2018

Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report

por Pastor, Danielle M., Lee-Wisdom, Katherine, Arai, Andrew E., Sirajuddin, Arlene, Rosing, Douglas R., Korchin, Borys, Gulley, James L., Bilusic, Marijo
Publicado 2020

Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells

por Hoke, Austin T.K., Padget, Michelle R., Fabian, Kellsye P., Nandal, Anjali, Gallia, Gary L., Bilusic, Marijo, Soon-Shiong, Patrick, Hodge, James W., London, Nyall R.
Publicado 2021

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

por Bilusic, Marijo, Heery, Christopher R., Collins, Julie M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Marté, Jennifer L., Strauss, Julius, Gatti-Mays, Margaret E., Schlom, Jeffrey, Gulley, James L.
Publicado 2019

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

por Del Rivero, Jaydira, Donahue, Renee N., Marté, Jennifer L., Gramza, Ann W., Bilusic, Marijo, Rauckhorst, Myrna, Cordes, Lisa, Merino, Maria J., Dahut, William L., Schlom, Jeffrey, Gulley, James L., Madan, Ravi A.
Publicado 2020

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

por Bilusic, Marijo, Toney, Nicole J., Donahue, Renee N., Wroblewski, Susan, Zibelman, Matthew, Ghatalia, Pooja, Ross, Eric A., Karzai, Fatima, Madan, Ravi A., Dahut, William L., Gulley, James L., Schlom, Jeffrey, Plimack, Elizabeth R., Geynisman, Daniel M.
Publicado 2022

Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable...

por DeMaria, Peter Joseph, Bilusic, Marijo, Park, Deric M., Heery, Christopher R., Donahue, Renee N., Madan, Ravi A., Bagheri, Mohammad Hadi, Strauss, Julius, Shen, Victoria, Marté, Jennifer L., Steinberg, Seth M., Schlom, Jeffrey, Gilbert, Mark R., Gulley, James L.
Publicado 2021

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

por Bilusic, Marijo, McMahon, Sheri, Madan, Ravi A, Karzai, Fatima, Tsai, Yo-Ting, Donahue, Renee N, Palena, Claudia, Jochems, Caroline, Marté, Jennifer L, Floudas, Charalampos, Strauss, Julius, Redman, Jason, Abdul Sater, Houssein, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Gulley, James L
Publicado 2021

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

por Gray, Phillip N., Vuong, Huy, Tsai, Pei, Lu, Hsaio-Mei, Mu, Wenbo, Hsuan, Vickie, Hoo, Jayne, Shah, Swati, Uyeda, Lisa, Fox, Susanne, Patel, Harshil, Janicek, Mike, Brown, Sandra, Dobrea, Lavinia, Wagman, Lawrence, Plimack, Elizabeth, Mehra, Ranee, Golemis, Erica A., Bilusic, Marijo, Zibelman, Matthew, Elliott, Aaron
Publicado 2016

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

por Gatti‐Mays, Margaret E., Redman, Jason M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Bilusic, Marijo, Sater, Houssein Abdul, Marté, Jennifer L., Cordes, Lisa M., McMahon, Sheri, Steinberg, Seth M., Orpia, Alanvin, Burmeister, Andrea, Schlom, Jeffrey, Gulley, James L., Strauss, Julius
Publicado 2019

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

por Abdul Sater, Houssein, Marté, Jennifer L, Donahue, Renee N, Walter-Rodriguez, Beatriz, Heery, Christopher R, Steinberg, Seth M, Cordes, Lisa M, Chun, Guinevere, Karzai, Fatima, Bilusic, Marijo, Harmon, Stephanie A, Turkbey, Ismail Baris, Choyke, Peter L, Schlom, Jeffrey, Dahut, William L, Madan, Ravi A, Pinto, Peter A, Gulley, James L
Publicado 2020

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

por DeMaria, Peter J, Lee-Wisdom, Katherine, Donahue, Renee N, Madan, Ravi A, Karzai, Fatima, Schwab, Angie, Palena, Claudia, Jochems, Caroline, Floudas, Charalampos, Strauss, Julius, Marté, Jennifer L, Redman, Jason Mark, Dombi, Eva, Widemann, Brigitte, Korchin, Borys, Adams, Tatiana, Pico-Navarro, Cesar, Heery, Christopher, Schlom, Jeffrey, Gulley, James L, Bilusic, Marijo
Publicado 2021

Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer

por Madan, Ravi A, Karzai, Fatima, Donahue, Renee N, Al-Harthy, Munjid, Bilusic, Marijo, Rosner, Inger I, Singh, Harpreet, Arlen, Philip M, Theoret, Marc R, Marté, Jennifer L, Cordes, Lisa, Couvillon, Anna, Hankin, Amy, Williams, Moniquea, Owens, Helen, Lochrin, Sarah E, Chau, Cindy H, Steinberg, Seth, Figg, William Douglas, Dahut, William, Schlom, Jeffrey, Gulley, James L
Publicado 2021

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

por Strauss, Julius, Gatti-Mays, Margaret E, Cho, Byoung Chul, Hill, Andrew, Salas, Sébastien, McClay, Edward, Redman, Jason M, Sater, Houssein A, Donahue, Renee N, Jochems, Caroline, Lamping, Elizabeth, Burmeister, Andrea, Marté, Jennifer L, Cordes, Lisa M, Bilusic, Marijo, Karzai, Fatima, Ojalvo, Laureen S, Jehl, Genevieve, Rolfe, P Alexander, Hinrichs, Christian S, Madan, Ravi A, Schlom, Jeffrey, Gulley, James L
Publicado 2020

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

por Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
Publicado 2018